Fc-enhanced anti-TIGIT antibody 30,278-IgG1 RMD amplifies antitumor immunity through effector cell activation and synergizes with PD-1 blockade
Fields of Study & Subjects
Monoclonal and Polyclonal Antibodies Research
Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Clinical Immunology
- Publisher
- Elsevier BV
- Volume
- 286
- Pages
- 110714–110714
- Publication date
- 14 May 2026
- Language
- EN